NCT05838768
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05838768
Title Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NOR | ITA | ISR | GBR | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
University of California LA Los Angeles California 90095 United States Details
UCSF San Francisco California 94115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering New York New York 10017 United States Details
Columbia University Medical Ctr New York New York 10032 United States Details
Univ of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Novartis Investigative Site Brussels 1200 Belgium Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Guangzhou 510655 China Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Milan MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Kashiwa Chiba 2778577 Japan Details
Novartis Investigative Site Oslo 0310 Norway Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Seoul 03722 South Korea Details
Novartis Investigative Site Barcelona 08035 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Valencia 46010 Spain Details
Novartis Investigative Site Stockholm 17176 Sweden Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site London SW3 6JJ United Kingdom Details
Novartis Investigative Site Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field